Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Testosterone inhibits osteoclast formation stimulated by parathyroid hormone through androgen receptor.

Chen, Qingxiang, Kaji, Hiroshi, Sugimoto, Toshitsugu, Chihara, Kazuo · 2001 · FEBS Letters

Abstract

Androgens play an important role in the regulation of bone metabolism in animals and humans. The present study was performed to investigate whether androgens would affect osteoclast formation stimulated by parathyroid hormone (PTH) in mouse bone cell cultures and its mechanism. Testosterone as well as α‐dihydrotestosterone (DHT) concentration‐dependently inhibited osteoclast formation induced by PTH‐(1‐34). 10−8 M ICI 182780, an estrogen receptor inhibitor, did not affect PTH‐induced osteoclast formation antagonized by 10−8 M testosterone, although it completely antagonized the effects of 10−8 M 17β‐estradiol. Moreover, 3 μM 4‐androsten‐4‐ol‐3,17‐dione, an aromatase inhibitor, did not affect PTH‐induced osteoclast formation antagonized by testosterone. Hydroxyflutamide, an androgen receptor antagonist, concentration‐dependently antagonized the inhibitory effects of testosterone as well as DHT on PTH‐stimulated osteoclast formation. In conclusion, the present study first demonstrated that testosterone inhibited osteoclast formation stimulated by PTH through the androgen receptor, but not through the production of intrinsic estrogen in mouse bone cell cultures.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0014-5793(01)02160-3

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 2

  1. 10.1210/endo.130.5.1572302 · doi:10.1210/endo.130.5.1572302 · Paper page
  2. 10.1210/en.137.6.2217 · doi:10.1210/en.137.6.2217

Cited by

See all 63

Metadata

Authors
Chen, Q., Kaji, H., Sugimoto, T., & Chihara, K.
Affiliations
Kobe University (JP)
Corresponding author
Sugimoto, Toshitsugu
Venue
FEBS Letters
Publisher
Wiley
Published
2001-02-20
Volume
491
Issue
1-2
Pages
91-93
ISSN
  • 0014-5793 (ISSN-L)
  • 1873-3468
OpenAlex
W1968430611
Cited by
63
References
20
Citations by year
2026: 2 · 2025: 3 · 2023: 4 · 2022: 1 · 2021: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 3 · 2012: 3
FWCI
1.16
Type
journal article
Language
en
Open access
closed
Locations
  • FEBS Letters (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
testosterone, osteoclastogenesis, parathyroid hormone, androgen receptor, bone metabolism, estrogen receptor, aromatase, hydroxyflutamide, bone cell culture
MeSH terms
Fulvestrant, Androgen Antagonists, Androstenedione, Animals, Cell Division, Cells, Cultured, Enzyme Inhibitors, Estradiol, Estrogen Antagonists, Flutamide, Glucuronates, Mice, Inbred ICR, Osteoclasts, Parathyroid Hormone, Receptors, Androgen, Dihydrotestosterone, Testosterone, Teriparatide, Aromatase Inhibitors, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Testosterone inhibits osteoclast formation stimulated by parathyroid hormone through androgen receptor. https://app.cochat.ai/papers/10.1016/s0014-5793(01)02160-3
The paper
Chen, Q., Kaji, H., Sugimoto, T., & Chihara, K. (2001). Testosterone inhibits osteoclast formation stimulated by parathyroid hormone through androgen receptor. FEBS Letters. https://doi.org/10.1016/s0014-5793(01)02160-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.